Marchantin A, a cyclic bis(bibenzyl ether), isolated from the liverwort Marchantia emarginata subsp. tosana induces apoptosis in human MCF-7 breast cancer cells

Cancer Letters

Volumn 291, Issue 1, 2010, Pages 108-119

  Huang, Wei Jan ^a   Wu, Chia Li ^b   Lin, Chia Wei ^c   Chi, Li Ling ^c   Chen, Pen Yuan ^c   Chiu, Chun Jung ^c   Huang, Chung Yang ^c   Chen, Chia Nan ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAMKANG UNIVERSITY   (Taiwan)

^c NatureWise Biotech and Medicals Corporation   (Taiwan)

Author keywords

Apoptosis; Breast cancer; Cyclic bis(bibenzyl ether); Marchantia tosana; Marchantin A

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN B1; CYCLIN D1; FREE RADICAL; MARCHANTIN A; PROTEIN BID; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL CYCLE REGULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; MARCHANTIA; MARCHANTIA EMARGINATA; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE;

APOPTOSIS; BIBENZYLS; BREAST NEOPLASMS; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; ETHERS, CYCLIC; FEMALE; FREE RADICAL SCAVENGERS; HUMANS;

MARCHANTIA; MARCHANTIA EMARGINATA; MARCHANTIOPHYTA;

EID: 77949874726     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.10.006     Document Type: Article

References (34)

1. Asakawa Y. Chemical constituents of the bryophytes. In: Herz W., Kibry G.W., Moore R.E., Steglich W., and Tamm Ch. (Eds). Progress in the Chemistry of Organic Natural Products 65 (1995) 1-618
2. Toyota M., Omatsu I., Braggins J., and Asakawa Y. New humulane-type sesquiterpenes from the liverworts Tylimanthus tenellus and Marchantia emarginata subsp. tosana. Chem. Pharm. Bull. (Tokyo) 52 (2004) 481-484
3. Niu C., Qu J.B., and Lou H.X. Antifungal bis(bibenzyls) from the Chinese liverwort Marchantia polymorpha L. Chem. Biodivers. 3 (2006) 34-40
4. Kámory E., Keserü G.M., and Papp B. Isolation and antibacterial activity of marchantin A, a cyclic bis(bibenzyl) constituent of Hungarian Marchantia polymorpha. Planta Med. 61 (1995) 387-388
5. Harinantenaina L., Quang D.N., Takeshi N., Hashimoto T., Kohchi C., Soma G., and Asakawa Y. Bis(bibenzyls) from liverworts inhibit lipopolysaccharide-induced inducible NOS in RAW 264.7 cells: a study of structure-activity relationships and molecular mechanism. J. Nat. Prod. 68 (2005) 1779-1781
6. Taira Z., Takei M., Endo K., Hashimoto T., Sakiya Y., and Asakawa Y. Marchantin A trimethyl ether: its molecular structure and tubocurarine-like skeletal muscle relaxation activity. Chem. Pharm. Bull. (Tokyo) 42 (1994) 52-56
7. Askawa Y. Phytochemistry of bryophytes: biologically active terpenoids and aromatic compounds from liverworts. In: Romeo J. (Ed). Phytochemicals in Human Health Protection, Nutrition, and Plant Defense vol. 33 (1999), Kluwer Academic/Plenum Publishers, New York 319-342
8. Wyllie A.H. Apoptosis: an overview. Br. Med. Bull. 53 (1997) 451-465
9. Don A.S., and Hogg P.J. Mitochondria as cancer drug targets. Trends Mol. Med. 10 (2004) 372-378
10. Grad J.M., Cepero E., and Boise L.H. Mitochondria as targets for established and novel anti-cancer agents. Drug Resist. Updates 4 (2001) 85-91
11. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
12. Fleury C., Mignotte B., and Vayssiere J.L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84 (2002) 131-141
13. Reeder J.G., and Vogel V.G. Breast cancer risk management. Clin. Breast Cancer 7 (2007) 833-840
14. Newman D.J., Cragg G.M., and Snader K.M. The influence of natural products upon drug discovery. Nat. Prod. Rep. 17 (2000) 215-234
15. 13C NMR spectra of marchantins isolated from liverworts and its application to structure determination of two new macrocyclic bis(bibenzyls). Tetrahedron Lett. 26 (1985) 4735-4738
16. Shi Y.Q., Zhu C.J., Yuan H.Q., Li B.Q., Gao J., Qu X.J., Sun B., Chen Y.N., Li S., Li X., and Lou H.X. Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro. Cancer Lett. 276 (2009) 160-170
17. Kuribayashi K., Mayes P.A., and El-Deiry W.S. What are caspases 3 and 7 doing upstream of the mitochondria?. Cancer Biol. Ther. 5 (2006) 763-765
18. Kruidering M., and Evan G.I. Caspase-8 in apoptosis: the beginning of "the end"?. IUBMB Life 50 (2000) 85-90
19. Caldon C.E., Daly R.J., Sutherland R.L., and Musgrove E.A. Cell cycle control in breast cancer cells. J. Cell Biochem. 1 (2006) 61-74
20. Dotto G.P. p21(WAF1/Cip1): more than a break to the cell cycle?. Biochim. Biophys. Acta 1471 (2000) 43-56
21. Pines J., and Hunter T. Cyclins A and B1 in the human cell cycle. CIBA Found. Symp. 170 (1992) 187-196
22. Knudsen K.E., Diehl J.A., Haiman C.A., and Knudsen E.S. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 13 (2006) 1620-1628
23. Lopez-Beltran A., MacLennan G.T., and Montironi R. Cyclin E as molecular marker in the management of breast cancer: a review. Anal. Quant. Cytol. Histol. 28 (2006) 111-114
24. 1 cyclin-dependent kinases. Genes Dev. 9 (1995) 1149-1163
25. Liu G., and Lozano G. p21 Stability: linking chaperones to a cell cycle checkpoint. Cancer Cell 7 (2005) 113-114
26. Kumagai T., Wakimoto N., Yin D., Gery S., Kawamata N., Takai N., Komatsu N., Chumakov A., Imai Y., and Koeffler H.P. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells. Int. J. Cancer 121 (2007) 656-665
27. 2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner. Biochem. Biophys. Res. Commun. 378 (2009) 326-331
28. Pajak B., Orzechowski A., and Gajkowska B. Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells. Adv. Med. Sci. 52 (2007) 83-88
29. Rosato R.R., Almenara J.A., Maggio S.C., Coe S., Atadja P., Dent P., and Grant S. Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions. Mol. Cancer Ther. 7 (2008) 3285-3297
30. Rosato R.R., Almenara J.A., and Grant S. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Cancer Res. 63 (2003) 3637-3645
31. Grunberger D., Banerjee R., Eisinger K., Oltz E.M., Efros L., Caldwell M., Estevez V., and Nakanishi K. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 15 (1988) 230-232
32. Cao G., Sofic E., and Prior R.L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Rad. Biol. Med. 22 (1997) 749-760
33. Wee L.M., Long L.H., Whiteman M., and Halliwell B. Factors affecting the ascorbate- and phenolic-dependent generation of hydrogen peroxide in Dulbecco's modified Eagle's medium. Free Rad. Res. 37 (2003) 1123-1130
34. Roques S.C., Landrault N., Teissèdre P.L., Laurent C., Besançon P., Rouane J.M., and Caporiccio B. Hydrogen peroxide generation in caco-2 cell culture medium by addition of phenolic compounds: effect of ascorbic acid. Free Rad. Res. 36 (2002) 593-599